A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy
- 5 January 1989
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 320 (1), 8-13
- https://doi.org/10.1056/nejm198901053200102
Abstract
We conducted a controlled trial to investigate the long-term effects of treatment with methylprednisolone and chlorambucil in patients with idiopathic membranous nephropathy. We have previously reported that after a mean of 31 months, treated patients did better. We now report the results of a longer follow-up.This publication has 28 references indexed in Scilit:
- A controlled trial of cyclophosphamide in patients with membranous glomerulonephritisKidney International, 1987
- Prognosis and treatment of membranous nephropathyKidney International, 1986
- Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.BMJ, 1985
- Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1984
- A Controlled Study of Short-Term Prednisone Treatment in Adults with Membranous NephropathyNew England Journal of Medicine, 1979
- Adjuvant chemotherapy in breast cancer—Swiss co-operative studiesCancer Treatment Reviews, 1979
- Treatment of Idiopathic Membranous NephropathyNew England Journal of Medicine, 1976
- Controlled trial of cyclophosphamide in idiopathic membranous nephropathyKidney International, 1974
- Controlled Trial of Prednisone in Adult Patients with the Nephrotic SyndromeBMJ, 1970
- On methods in the analysis of profile dataPsychometrika, 1959